Tianda Pharmaceuticals Limited (HKG:0455)
0.0930
+0.0010 (1.09%)
Jul 8, 2026, 2:45 PM HKT
Tianda Pharmaceuticals Market Cap
Tianda Pharmaceuticals has a market cap or net worth of 197.8 million as of July 10, 2026. Its market cap has decreased by -38.67% in one year.
Market Cap
197.80M
Enterprise Value
258.77M
Revenue
322.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since October 27, 1993, Tianda Pharmaceuticals's market cap has decreased from 315.36M to 197.80M, a decrease of -37.28%. That is a compound annual growth rate of -1.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 197.80M | -28.68% |
| Dec 31, 2025 | 277.36M | -23.67% |
| Dec 31, 2024 | 363.36M | -22.48% |
| Dec 29, 2023 | 468.71M | -46.17% |
| Dec 30, 2022 | 870.77M | 26.56% |
| Dec 31, 2021 | 688.01M | 131.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lee's Pharmaceutical Holdings | 630.05M |
| Zhongzhi Pharmaceutical Holdings | 595.88M |
| China NT Pharma Group Company | 398.58M |
| Wai Yuen Tong Medicine Holdings | 323.17M |
| Regent Pacific Group | 274.31M |
| Shenzhen Neptunus Interlong Bio-technique Company | 204.72M |
| Extrawell Pharmaceutical Holdings | 203.00M |
| PuraPharm Corporation | 160.52M |